{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T11:37:36Z","timestamp":1769859456059,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["trasci.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.transci.2024.104039","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T08:16:45Z","timestamp":1732090605000},"page":"104039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of different concentrations of calcium gluconate added in replacement fluid to maintain ionised calcium levels during therapeutic plasma exchange procedures"],"prefix":"10.1016","volume":"64","author":[{"given":"Nippun","family":"Prinja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rekha","family":"Hans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aarushi","family":"Sahni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangeeta","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preeti","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divjot Singh","family":"Lamba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aastha","family":"Takkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthik Vinay","family":"Mahesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratti Ram","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2024.104039_bib1","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM196009222631202","article-title":"Treatment of Waldenstr\u00f6m's macroglobulinemia by plasmapheresis","volume":"263","author":"Schwab","year":"1960","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2024.104039_bib2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic Purpura. Canadian apheresis study group","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2024.104039_bib3","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2024.104039_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for Apheresis: the eight special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"issue":"6","key":"10.1016\/j.transci.2024.104039_bib5","first-page":"491","article-title":"Effect of plasma unit weight and donor sex on post-donation citrate level: an experimental study on plasmapheresis donors","volume":"50","author":"Marraccini","year":"2023","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.transci.2024.104039_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jca.2920010306","article-title":"Dosage regimens for citrate anticoagulants","volume":"1","author":"Hester","year":"1983","journal-title":"J Clin Apher"},{"issue":"9","key":"10.1016\/j.transci.2024.104039_bib7","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1046\/j.1537-2995.2001.41091165.x","article-title":"Comprehensive analysis of citrate effects during plateletpheresis in normal donors","volume":"41","author":"Bolan","year":"2001","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.transci.2024.104039_bib8","first-page":"170","article-title":"The effect of donor\u2019s characteristics on plasmapheresis products: insights for a personalised approach","volume":"18","author":"Merolle","year":"2020","journal-title":"Blood Transfus"},{"key":"10.1016\/j.transci.2024.104039_bib9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/jca.10000","article-title":"Hypocalcemic toxicity and atypical reactions in therapeutic plasma exchange","volume":"16","author":"Weinstein","year":"2001","journal-title":"J Clin Apher"},{"issue":"5","key":"10.1016\/j.transci.2024.104039_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jca.20142","article-title":"Continuous infusion of calcium gluconate in 5\u2009% albumin is safe and prevents most hypocalcemic reactions during therapeutic plasma exchange","volume":"22","author":"Kankirawatana","year":"2007","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2024.104039_bib11","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1046\/j.1537-2995.2003.00571.x","article-title":"Reduction of adverse citrate reactions during autologous large-volume PBPC apheresis by continuous infusion of calcium\u2013gluconate","volume":"43","author":"Buchta","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2024.104039_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/17562864231154306","article-title":"Comparison of IVIg and TPE efficacy in the treatment of neurological disorders: a systematic literature review","volume":"16","author":"Pinto","year":"2023","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.transci.2024.104039_bib14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e318207b1f6","article-title":"Evidence-based guideline update: plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"76","author":"Cortese","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.transci.2024.104039_bib15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/jca.21648","article-title":"Pro phylactic infusion of calcium gluconate to prevent a symptomatic fall in plasma ionized calcium during therapeutic plasma exchange: a comparison of two methods","volume":"33","author":"Zhao","year":"2018","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2024.104039_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.transci.2015.11.015","article-title":"Prophylactic low dose continuous calcium infusion during peripheral blood stem cell (PBSC) collections to reduce citrate related toxicity","volume":"54","author":"Hegde","year":"2016","journal-title":"Transfus Apher Sci"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224002209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224002209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T08:48:06Z","timestamp":1738572486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050224002209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1473050224002209"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2024.104039","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of different concentrations of calcium gluconate added in replacement fluid to maintain ionised calcium levels during therapeutic plasma exchange procedures","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2024.104039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104039"}}